0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dermatology Drugs for Pets Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-8J8253
Home | Market Reports | Health| Pharmacy
Global and China Dermatology Drugs for Pets Market Insights Forecast to 2027
BUY CHAPTERS

Global Dermatology Drugs for Pets Market Research Report 2025

Code: QYRE-Auto-8J8253
Report
July 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dermatology Drugs for Pets Market Size

The global market for Dermatology Drugs for Pets was valued at US$ 323 million in the year 2024 and is projected to reach a revised size of US$ 394 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Dermatology Drugs for Pets Market

Dermatology Drugs for Pets Market

Topical (on the body surface) application of medicine can be used to treat specific areas, such as patches of skin, or as a simple way of giving medicine to a patient because some drugs are taken up through the skin into the body.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 46%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dermatology Drugs for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology Drugs for Pets.
The Dermatology Drugs for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dermatology Drugs for Pets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatology Drugs for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dermatology Drugs for Pets Market Report

Report Metric Details
Report Name Dermatology Drugs for Pets Market
Accounted market size in year US$ 323 million
Forecasted market size in 2031 US$ 394 million
CAGR 2.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer Animal Health, Boehringer Ingelheim Vetmedica, Ceva Sante Animale, Zoetis Inc., Elanco, IDEXX Laboratories, Merial, Vetoquinol S.A.panies, Virbac S.A.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dermatology Drugs for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dermatology Drugs for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Dermatology Drugs for Pets Market growing?

Ans: The Dermatology Drugs for Pets Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Dermatology Drugs for Pets Market size in 2031?

Ans: The Dermatology Drugs for Pets Market size in 2031 will be US$ 394 million.

Who are the main players in the Dermatology Drugs for Pets Market report?

Ans: The main players in the Dermatology Drugs for Pets Market are Bayer Animal Health, Boehringer Ingelheim Vetmedica, Ceva Sante Animale, Zoetis Inc., Elanco, IDEXX Laboratories, Merial, Vetoquinol S.A.panies, Virbac S.A.

What are the Application segmentation covered in the Dermatology Drugs for Pets Market report?

Ans: The Applications covered in the Dermatology Drugs for Pets Market report are Pets Clinics, Pets Hospitals, Others

What are the Type segmentation covered in the Dermatology Drugs for Pets Market report?

Ans: The Types covered in the Dermatology Drugs for Pets Market report are Antibiotics, Antifungal Drugs, Others

Recommended Reports

Veterinary Pharmaceuticals

Pet Care Products

Veterinary Diagnostics

1 Dermatology Drugs for Pets Market Overview
1.1 Product Definition
1.2 Dermatology Drugs for Pets by Type
1.2.1 Global Dermatology Drugs for Pets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Antibiotics
1.2.3 Antifungal Drugs
1.2.4 Others
1.3 Dermatology Drugs for Pets by Application
1.3.1 Global Dermatology Drugs for Pets Market Value by Application (2024 VS 2031)
1.3.2 Pets Clinics
1.3.3 Pets Hospitals
1.3.4 Others
1.4 Global Dermatology Drugs for Pets Market Size Estimates and Forecasts
1.4.1 Global Dermatology Drugs for Pets Revenue 2020-2031
1.4.2 Global Dermatology Drugs for Pets Sales 2020-2031
1.4.3 Global Dermatology Drugs for Pets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dermatology Drugs for Pets Market Competition by Manufacturers
2.1 Global Dermatology Drugs for Pets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dermatology Drugs for Pets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dermatology Drugs for Pets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dermatology Drugs for Pets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dermatology Drugs for Pets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dermatology Drugs for Pets, Product Type & Application
2.7 Global Key Manufacturers of Dermatology Drugs for Pets, Date of Enter into This Industry
2.8 Global Dermatology Drugs for Pets Market Competitive Situation and Trends
2.8.1 Global Dermatology Drugs for Pets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dermatology Drugs for Pets Players Market Share by Revenue
2.8.3 Global Dermatology Drugs for Pets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dermatology Drugs for Pets Market Scenario by Region
3.1 Global Dermatology Drugs for Pets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dermatology Drugs for Pets Sales by Region: 2020-2031
3.2.1 Global Dermatology Drugs for Pets Sales by Region: 2020-2025
3.2.2 Global Dermatology Drugs for Pets Sales by Region: 2026-2031
3.3 Global Dermatology Drugs for Pets Revenue by Region: 2020-2031
3.3.1 Global Dermatology Drugs for Pets Revenue by Region: 2020-2025
3.3.2 Global Dermatology Drugs for Pets Revenue by Region: 2026-2031
3.4 North America Dermatology Drugs for Pets Market Facts & Figures by Country
3.4.1 North America Dermatology Drugs for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dermatology Drugs for Pets Sales by Country (2020-2031)
3.4.3 North America Dermatology Drugs for Pets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dermatology Drugs for Pets Market Facts & Figures by Country
3.5.1 Europe Dermatology Drugs for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dermatology Drugs for Pets Sales by Country (2020-2031)
3.5.3 Europe Dermatology Drugs for Pets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dermatology Drugs for Pets Market Facts & Figures by Region
3.6.1 Asia Pacific Dermatology Drugs for Pets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dermatology Drugs for Pets Sales by Region (2020-2031)
3.6.3 Asia Pacific Dermatology Drugs for Pets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dermatology Drugs for Pets Market Facts & Figures by Country
3.7.1 Latin America Dermatology Drugs for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dermatology Drugs for Pets Sales by Country (2020-2031)
3.7.3 Latin America Dermatology Drugs for Pets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dermatology Drugs for Pets Market Facts & Figures by Country
3.8.1 Middle East and Africa Dermatology Drugs for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dermatology Drugs for Pets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dermatology Drugs for Pets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dermatology Drugs for Pets Sales by Type (2020-2031)
4.1.1 Global Dermatology Drugs for Pets Sales by Type (2020-2025)
4.1.2 Global Dermatology Drugs for Pets Sales by Type (2026-2031)
4.1.3 Global Dermatology Drugs for Pets Sales Market Share by Type (2020-2031)
4.2 Global Dermatology Drugs for Pets Revenue by Type (2020-2031)
4.2.1 Global Dermatology Drugs for Pets Revenue by Type (2020-2025)
4.2.2 Global Dermatology Drugs for Pets Revenue by Type (2026-2031)
4.2.3 Global Dermatology Drugs for Pets Revenue Market Share by Type (2020-2031)
4.3 Global Dermatology Drugs for Pets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dermatology Drugs for Pets Sales by Application (2020-2031)
5.1.1 Global Dermatology Drugs for Pets Sales by Application (2020-2025)
5.1.2 Global Dermatology Drugs for Pets Sales by Application (2026-2031)
5.1.3 Global Dermatology Drugs for Pets Sales Market Share by Application (2020-2031)
5.2 Global Dermatology Drugs for Pets Revenue by Application (2020-2031)
5.2.1 Global Dermatology Drugs for Pets Revenue by Application (2020-2025)
5.2.2 Global Dermatology Drugs for Pets Revenue by Application (2026-2031)
5.2.3 Global Dermatology Drugs for Pets Revenue Market Share by Application (2020-2031)
5.3 Global Dermatology Drugs for Pets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer Animal Health
6.1.1 Bayer Animal Health Company Information
6.1.2 Bayer Animal Health Description and Business Overview
6.1.3 Bayer Animal Health Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Animal Health Dermatology Drugs for Pets Product Portfolio
6.1.5 Bayer Animal Health Recent Developments/Updates
6.2 Boehringer Ingelheim Vetmedica
6.2.1 Boehringer Ingelheim Vetmedica Company Information
6.2.2 Boehringer Ingelheim Vetmedica Description and Business Overview
6.2.3 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Product Portfolio
6.2.5 Boehringer Ingelheim Vetmedica Recent Developments/Updates
6.3 Ceva Sante Animale
6.3.1 Ceva Sante Animale Company Information
6.3.2 Ceva Sante Animale Description and Business Overview
6.3.3 Ceva Sante Animale Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ceva Sante Animale Dermatology Drugs for Pets Product Portfolio
6.3.5 Ceva Sante Animale Recent Developments/Updates
6.4 Zoetis Inc.
6.4.1 Zoetis Inc. Company Information
6.4.2 Zoetis Inc. Description and Business Overview
6.4.3 Zoetis Inc. Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zoetis Inc. Dermatology Drugs for Pets Product Portfolio
6.4.5 Zoetis Inc. Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Company Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Elanco Dermatology Drugs for Pets Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 IDEXX Laboratories
6.6.1 IDEXX Laboratories Company Information
6.6.2 IDEXX Laboratories Description and Business Overview
6.6.3 IDEXX Laboratories Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 IDEXX Laboratories Dermatology Drugs for Pets Product Portfolio
6.6.5 IDEXX Laboratories Recent Developments/Updates
6.7 Merial
6.7.1 Merial Company Information
6.7.2 Merial Description and Business Overview
6.7.3 Merial Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merial Dermatology Drugs for Pets Product Portfolio
6.7.5 Merial Recent Developments/Updates
6.8 Vetoquinol S.A.panies
6.8.1 Vetoquinol S.A.panies Company Information
6.8.2 Vetoquinol S.A.panies Description and Business Overview
6.8.3 Vetoquinol S.A.panies Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vetoquinol S.A.panies Dermatology Drugs for Pets Product Portfolio
6.8.5 Vetoquinol S.A.panies Recent Developments/Updates
6.9 Virbac S.A.
6.9.1 Virbac S.A. Company Information
6.9.2 Virbac S.A. Description and Business Overview
6.9.3 Virbac S.A. Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Virbac S.A. Dermatology Drugs for Pets Product Portfolio
6.9.5 Virbac S.A. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dermatology Drugs for Pets Industry Chain Analysis
7.2 Dermatology Drugs for Pets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dermatology Drugs for Pets Production Mode & Process Analysis
7.4 Dermatology Drugs for Pets Sales and Marketing
7.4.1 Dermatology Drugs for Pets Sales Channels
7.4.2 Dermatology Drugs for Pets Distributors
7.5 Dermatology Drugs for Pets Customer Analysis
8 Dermatology Drugs for Pets Market Dynamics
8.1 Dermatology Drugs for Pets Industry Trends
8.2 Dermatology Drugs for Pets Market Drivers
8.3 Dermatology Drugs for Pets Market Challenges
8.4 Dermatology Drugs for Pets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dermatology Drugs for Pets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dermatology Drugs for Pets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dermatology Drugs for Pets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dermatology Drugs for Pets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Dermatology Drugs for Pets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dermatology Drugs for Pets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dermatology Drugs for Pets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dermatology Drugs for Pets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dermatology Drugs for Pets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dermatology Drugs for Pets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dermatology Drugs for Pets, Product Type & Application
 Table 12. Global Key Manufacturers of Dermatology Drugs for Pets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dermatology Drugs for Pets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology Drugs for Pets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dermatology Drugs for Pets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dermatology Drugs for Pets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Dermatology Drugs for Pets Sales Market Share by Region (2020-2025)
 Table 19. Global Dermatology Drugs for Pets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Dermatology Drugs for Pets Sales Market Share by Region (2026-2031)
 Table 21. Global Dermatology Drugs for Pets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dermatology Drugs for Pets Revenue Market Share by Region (2020-2025)
 Table 23. Global Dermatology Drugs for Pets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dermatology Drugs for Pets Revenue Market Share by Region (2026-2031)
 Table 25. North America Dermatology Drugs for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dermatology Drugs for Pets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Dermatology Drugs for Pets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Dermatology Drugs for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dermatology Drugs for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dermatology Drugs for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dermatology Drugs for Pets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Dermatology Drugs for Pets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Dermatology Drugs for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dermatology Drugs for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dermatology Drugs for Pets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dermatology Drugs for Pets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Dermatology Drugs for Pets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Dermatology Drugs for Pets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dermatology Drugs for Pets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dermatology Drugs for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dermatology Drugs for Pets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Dermatology Drugs for Pets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Dermatology Drugs for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dermatology Drugs for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dermatology Drugs for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dermatology Drugs for Pets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Dermatology Drugs for Pets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Dermatology Drugs for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dermatology Drugs for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dermatology Drugs for Pets Sales (K Units) by Type (2020-2025)
 Table 51. Global Dermatology Drugs for Pets Sales (K Units) by Type (2026-2031)
 Table 52. Global Dermatology Drugs for Pets Sales Market Share by Type (2020-2025)
 Table 53. Global Dermatology Drugs for Pets Sales Market Share by Type (2026-2031)
 Table 54. Global Dermatology Drugs for Pets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dermatology Drugs for Pets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dermatology Drugs for Pets Revenue Market Share by Type (2020-2025)
 Table 57. Global Dermatology Drugs for Pets Revenue Market Share by Type (2026-2031)
 Table 58. Global Dermatology Drugs for Pets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Dermatology Drugs for Pets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Dermatology Drugs for Pets Sales (K Units) by Application (2020-2025)
 Table 61. Global Dermatology Drugs for Pets Sales (K Units) by Application (2026-2031)
 Table 62. Global Dermatology Drugs for Pets Sales Market Share by Application (2020-2025)
 Table 63. Global Dermatology Drugs for Pets Sales Market Share by Application (2026-2031)
 Table 64. Global Dermatology Drugs for Pets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dermatology Drugs for Pets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dermatology Drugs for Pets Revenue Market Share by Application (2020-2025)
 Table 67. Global Dermatology Drugs for Pets Revenue Market Share by Application (2026-2031)
 Table 68. Global Dermatology Drugs for Pets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Dermatology Drugs for Pets Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer Animal Health Company Information
 Table 71. Bayer Animal Health Description and Business Overview
 Table 72. Bayer Animal Health Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Animal Health Dermatology Drugs for Pets Product
 Table 74. Bayer Animal Health Recent Developments/Updates
 Table 75. Boehringer Ingelheim Vetmedica Company Information
 Table 76. Boehringer Ingelheim Vetmedica Description and Business Overview
 Table 77. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Product
 Table 79. Boehringer Ingelheim Vetmedica Recent Developments/Updates
 Table 80. Ceva Sante Animale Company Information
 Table 81. Ceva Sante Animale Description and Business Overview
 Table 82. Ceva Sante Animale Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Ceva Sante Animale Dermatology Drugs for Pets Product
 Table 84. Ceva Sante Animale Recent Developments/Updates
 Table 85. Zoetis Inc. Company Information
 Table 86. Zoetis Inc. Description and Business Overview
 Table 87. Zoetis Inc. Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Zoetis Inc. Dermatology Drugs for Pets Product
 Table 89. Zoetis Inc. Recent Developments/Updates
 Table 90. Elanco Company Information
 Table 91. Elanco Description and Business Overview
 Table 92. Elanco Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Elanco Dermatology Drugs for Pets Product
 Table 94. Elanco Recent Developments/Updates
 Table 95. IDEXX Laboratories Company Information
 Table 96. IDEXX Laboratories Description and Business Overview
 Table 97. IDEXX Laboratories Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. IDEXX Laboratories Dermatology Drugs for Pets Product
 Table 99. IDEXX Laboratories Recent Developments/Updates
 Table 100. Merial Company Information
 Table 101. Merial Description and Business Overview
 Table 102. Merial Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merial Dermatology Drugs for Pets Product
 Table 104. Merial Recent Developments/Updates
 Table 105. Vetoquinol S.A.panies Company Information
 Table 106. Vetoquinol S.A.panies Description and Business Overview
 Table 107. Vetoquinol S.A.panies Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Vetoquinol S.A.panies Dermatology Drugs for Pets Product
 Table 109. Vetoquinol S.A.panies Recent Developments/Updates
 Table 110. Virbac S.A. Company Information
 Table 111. Virbac S.A. Description and Business Overview
 Table 112. Virbac S.A. Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Virbac S.A. Dermatology Drugs for Pets Product
 Table 114. Virbac S.A. Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Dermatology Drugs for Pets Distributors List
 Table 118. Dermatology Drugs for Pets Customers List
 Table 119. Dermatology Drugs for Pets Market Trends
 Table 120. Dermatology Drugs for Pets Market Drivers
 Table 121. Dermatology Drugs for Pets Market Challenges
 Table 122. Dermatology Drugs for Pets Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dermatology Drugs for Pets
 Figure 2. Global Dermatology Drugs for Pets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dermatology Drugs for Pets Market Share by Type: 2024 & 2031
 Figure 4. Antibiotics Product Picture
 Figure 5. Antifungal Drugs Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Dermatology Drugs for Pets Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Dermatology Drugs for Pets Market Share by Application: 2024 & 2031
 Figure 9. Pets Clinics
 Figure 10. Pets Hospitals
 Figure 11. Others
 Figure 12. Global Dermatology Drugs for Pets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Dermatology Drugs for Pets Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Dermatology Drugs for Pets Sales (2020-2031) & (K Units)
 Figure 15. Global Dermatology Drugs for Pets Average Price (US$/Unit) & (2020-2031)
 Figure 16. Dermatology Drugs for Pets Report Years Considered
 Figure 17. Dermatology Drugs for Pets Sales Share by Manufacturers in 2024
 Figure 18. Global Dermatology Drugs for Pets Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Dermatology Drugs for Pets Players: Market Share by Revenue in Dermatology Drugs for Pets in 2024
 Figure 20. Dermatology Drugs for Pets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Dermatology Drugs for Pets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Dermatology Drugs for Pets Sales Market Share by Country (2020-2031)
 Figure 23. North America Dermatology Drugs for Pets Revenue Market Share by Country (2020-2031)
 Figure 24. United States Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Dermatology Drugs for Pets Sales Market Share by Country (2020-2031)
 Figure 27. Europe Dermatology Drugs for Pets Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Dermatology Drugs for Pets Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Dermatology Drugs for Pets Revenue Market Share by Region (2020-2031)
 Figure 35. China Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Dermatology Drugs for Pets Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Dermatology Drugs for Pets Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Dermatology Drugs for Pets Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Dermatology Drugs for Pets Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Dermatology Drugs for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Dermatology Drugs for Pets by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Dermatology Drugs for Pets by Type (2020-2031)
 Figure 56. Global Dermatology Drugs for Pets Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Dermatology Drugs for Pets by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Dermatology Drugs for Pets by Application (2020-2031)
 Figure 59. Global Dermatology Drugs for Pets Price (US$/Unit) by Application (2020-2031)
 Figure 60. Dermatology Drugs for Pets Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart